TLR3 and breast cancer: Next, a Kaplan–Meier plotter revealed that TNBC with high TLR3 expression had a better prognosis than breast cancer with low TLR3 expression (Fig. 3F, HR = 0.58, 95% confidence interval [CI]: 0.38–0.88, p = 0.0091).